Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
6(43%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
29%
Ph phase_3
4
29%
Ph phase_1
6
43%

Phase Distribution

6

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
6(42.9%)
Phase 2Efficacy & side effects
4(28.6%)
Phase 3Large-scale testing
4(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

14

all time

Status Distribution
Active(7)
Completed(6)
Other(1)

Detailed Status

Completed6
Active, not recruiting5
unknown1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (42.9%)
Phase 24 (28.6%)
Phase 34 (28.6%)

Trials by Status

active_not_recruiting536%
unknown17%
completed643%
not_yet_recruiting17%
recruiting17%

Recent Activity

6 active trials
Showing 5 of 14
active_not_recruitingphase_3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects

NCT06728124
active_not_recruitingphase_3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

NCT06777238
recruitingphase_3

Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects

NCT07150975
active_not_recruitingphase_3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

NCT06778967
active_not_recruitingphase_2

A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

NCT07055386
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06728124Phase 3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects

Active Not Recruiting
NCT06777238Phase 3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Active Not Recruiting
NCT07150975Phase 3

Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects

Recruiting
NCT06778967Phase 3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Active Not Recruiting
NCT07055386Phase 2

A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Active Not Recruiting
NCT06256562Phase 2

A Study of GZR18 Injection in Obese/Overweight Patients

Completed
NCT06737042Phase 2

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Not Yet Recruiting
NCT06548945Phase 1

A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

Completed
NCT06548997Phase 1

A Phase I Study of GZR18 Injection in Healthy Subjects

Completed
NCT06554054Phase 1

A Study of GZR18 Tablet in Chinese Healthy Subjects

Active Not Recruiting
NCT06256549Phase 2

A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus

Unknown
NCT06256536Phase 1

A Study of GZR18 Injection in Chinese Obese/Overweight Patients

Completed
NCT06256523Phase 1

A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Completed
NCT05328726Phase 1

Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14